Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CERTOLIZUMAB PEGOL Cause Monocyte count increased? 27 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Monocyte count increased have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.0% of all adverse event reports for CERTOLIZUMAB PEGOL.

27
Reports of Monocyte count increased with CERTOLIZUMAB PEGOL
0.0%
of all CERTOLIZUMAB PEGOL reports
0
Deaths
26
Hospitalizations

How Dangerous Is Monocyte count increased From CERTOLIZUMAB PEGOL?

Of the 27 reports, 26 (96.3%) required hospitalization, and 1 (3.7%) were considered life-threatening.

Is Monocyte count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663) Alopecia (9,111) Maternal exposure during pregnancy (9,013) Arthralgia (8,993) Abdominal discomfort (8,615)

What Other Drugs Cause Monocyte count increased?

CLOZAPINE (582) RITUXIMAB (327) ADALIMUMAB (208) ETANERCEPT (199) METHOTREXATE (176) TOCILIZUMAB (168) PREDNISONE (138) HYDROXYCHLOROQUINE (133) SULFASALAZINE (132) INFLIXIMAB (129)

Which CERTOLIZUMAB PEGOL Alternatives Have Lower Monocyte count increased Risk?

CERTOLIZUMAB PEGOL vs CERTOPARIN CERTOLIZUMAB PEGOL vs CETIRIZINE CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE CERTOLIZUMAB PEGOL vs CETRIMIDE CERTOLIZUMAB PEGOL vs CETRORELIX

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Monocyte count increased Reports All Drugs Causing Monocyte count increased CERTOLIZUMAB PEGOL Demographics